Read Oxford Handbook of Midwifery Online
Authors: Janet Medforth,Sue Battersby,Maggie Evans,Beverley Marsh,Angela Walker
p. 572).
Follow-up
Points to remember
Following birth
CHAPTER 22
Contraception
540
Antibiotic therapy
Any period of antibiotic therapy will not affect the uptake of this pill and the woman should continue to take it as normal. No additional barrier protection is required.
Antiretroviral therapy
HIV positive women on antiretroviral therapy should be advised to use consistent additional barrier contraception.
Nausea and vomiting
If the woman vomits within 3h of taking the pill, she may not have absorbed a sufficient amount of the pill for it to be effective. In this case, a condom should also be used for every act of sexual intercourse for the duration of the episode of illness involving vomiting and for the next 7 days, to allow the contraceptive effect to return. If she does not follow this advice, additional emergency contraception may be required (b see Emergency contraception, p. 572).
Drug interactions and the pill
Certain drugs
may
inhibit absorption or reduce the effectiveness of the
POP, so it is imperative to check whether or not the woman is taking any other medication when discussing possible use of the pill. However, it is very unusual to find a drug that will inhibit the POP uptake and effectiveness.
1
Guillebaud J (2008).
Contraception Today
, 6th edn. London: Taylor and Francis.
This page intentionally left blank
CHAPTER 22
Contraception
542
Implant
Known as Nexplanon
®
in the UK (Implanon
®
previously available). The contraceptive implant offers 3 years’ contraception, being most effective in the first 2 years.
Content
The implant is a single rate-limiting polymer capsule, 4cm long and 2mm in diameter, containing 68mg etonogestrel, which is released at over 30micrograms/day to inhibit ovulation.
Benefits
Mode of action
•
The hormone is released directly into the surrounding interstitial tissue and absorbed by capillaries into the bloodstream.
Insertion
Points to remember
IMPLANT
Fig. 22.4
Implanon
®
capsule showing position in arm. © Family Planning Association 2009, reprinted by permission of the publisher.
543